Skip to Main Content

Paper Details

Risk-stratified management to remove low-risk penicillin allergy labels in the patients with COVID-19 in the intensive care unit.
J Allergy Clin Immunol Pract
6
2023
COVID-19, patients, penicillin
Anti-Bacterial Agents, COVID-19, Drug Hypersensitivity, Humans, Hypersensitivity, Intensive Care Units, Penicillins
Author NameAffiliation
Joanna L StollingsDepartment of Pharmaceutical Services, Vanderbilt University Medical Center
Grace KooVanderbilt University Medical Center
Christopher J LindsellVanderbilt University Medical Center
Mary Lynn DearVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Mary Lynn DearVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Allison McCoyVanderbilt University Medical Center
Todd W RiceVanderbilt University Medical Center
Elizabeth J PhillipsVanderbilt University School of Medicine, Tenn Institute for Immunology & Infectious Diseases, Murdoch University
Cosby A StoneVanderbilt University Medical Center
  • 1 - 9

Datasets

Release 1.2